Department of Midwifery, College of Medicine and Health Science, Adigrat University, Adigrat, Tigray, Ethiopia.
Department of Public Health, PhD Fellow at Dilla University, Dilla, Ethiopia.
BMC Womens Health. 2023 Jun 27;23(1):338. doi: 10.1186/s12905-023-02479-w.
Cervical cancer is the leading cause of disability and mortality among women in Africa. Despite a significant correlation between HIV/AIDS and cervical cancer, there is unacceptably low coverage of the uptake of cervical cancer screening among human immunodeficiency virus-positive women in Sub-Saharan Africa. Individual primary studies are limited in explaining the patterns of uptake of cervical cancer screening. This review therefore considers the uptake of cervical cancer screening and its barriers among human immunodeficiency virus-positive women in Sub-Saharan Africa.
We systematically searched articles published until December , 2019, from the PubMed, Cochrane Library, POP LINE, Google Scholar, African Journals Online and JURN databases. The quality of the included articles was assessed by using the Newcastle‒Ottawa Scale, and the coverage of uptake of cervical cancer screening was pooled after checking for heterogeneity and publication bias. The random effect model was used, and subgroup analysis estimates were performed by country.
Twenty-one studies comprising 20,672 human immunodeficiency virus-positive women were included. Applying a random effect model, the overall cervical cancer screening uptake among this group of women in Sub-Saharan Africa was estimated to be 30% (95% CI: 19, 41, I = 100%). The main barriers to uptake of cervical screening include poor knowledge about cervical cancer and screening, low risk perception of cervical cancer, fear of test result and fear of screening as painful, lack of access to screening services, high cost of screening service, and poor partner attitude and acceptance of the service. The perception of an additional burden of having a cervical cancer diagnosis was found to be a unique barrier among this population of women.
The unacceptably low coverage of uptake of cervical cancer screening would indicate that the need to scale up the opportunities to these groups of women as well. This review revealed that in addition to structural and health care system barriers, sociocultural and personal barriers are powerful barriers in HIV-positive women. For these cohorts of population, a particular obstacle was discovered to be perception of an additional burden of having cervical cancer.
在非洲,宫颈癌是导致女性残疾和死亡的主要原因。尽管艾滋病毒/艾滋病与宫颈癌之间存在显著相关性,但撒哈拉以南非洲地区艾滋病毒阳性妇女接受宫颈癌筛查的比例低得令人无法接受。个别初步研究在解释宫颈癌筛查的接受模式方面存在局限性。因此,本综述考虑了撒哈拉以南非洲地区艾滋病毒阳性妇女接受宫颈癌筛查及其障碍。
我们系统地检索了截至 2019 年 12 月在 PubMed、Cochrane 图书馆、POPLINE、Google Scholar、African Journals Online 和 JURN 数据库上发表的文章。使用纽卡斯尔-渥太华量表评估纳入文章的质量,并在检查异质性和发表偏倚后汇总宫颈癌筛查的覆盖率。使用随机效应模型,并按国家进行亚组分析估计。
纳入了 21 项研究,共 20672 名艾滋病毒阳性妇女。采用随机效应模型,估计撒哈拉以南非洲地区这一人群的宫颈癌筛查总体接受率为 30%(95%CI:19,41,I=100%)。接受筛查的主要障碍包括对宫颈癌和筛查缺乏了解、对宫颈癌风险的低认知、对检测结果的恐惧、对筛查过程的恐惧、缺乏筛查服务、筛查服务费用高以及伴侣对该服务的态度和接受程度差。发现对宫颈癌诊断带来额外负担的看法是该人群中特有的障碍。
接受宫颈癌筛查的比例低得令人无法接受,这表明需要为这些妇女群体扩大机会。本综述显示,除了结构和医疗保健系统障碍外,社会文化和个人障碍也是艾滋病毒阳性妇女的强大障碍。对于这些人群,发现一个特别的障碍是对宫颈癌带来额外负担的看法。